Kinetic studies and structure-activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds. 1986

C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu

The kinetics of the reactivation of acetylcholinesterase inhibited by isopropyl methylphosphonofluoridate was studied. The reactivators used include nine bispyridinium monooximes and three bispyridinium dioximes. The dissociation constant (Kd) and the rate constant (k2) of dephosphorylation of the complex formed from the organophosphorus acetylcholinesterase (OP-AChE) and the oxime were measured. The reactivation parameters obtained from the in vitro kinetic studies were used to elucidate the structure-activity relationships. The hydrophobic property of a nonoxime substituent at the 3-position on the pyridinium ring can exert a positive effect on their binding affinity to OP-AChE. However, the rate constants (k2) of the nucleophilic displacement of OP-AChE by oximes depend negatively on these physical and structural factors of the oximes. The correlations of the in vivo antidotal efficacy (ED50) of these bispyridinium oximes have been analyzed with their pharmacological properties, e.g., reactivation potency, antimuscarinic activities, and antinicotinic activities. However, no satisfactory correlations were observed. It may be concluded that the detoxication mechanism of poisoning by isopropyl methylphosphonofluoridate is different from those of pinacolyl methylphosphonofluoridate and paraoxon.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002801 Cholinesterase Reactivators Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. Insecticides, Organophosphate, Antagonists,Insecticides, Organothiophosphate, Antagonists,Organophosphate Insecticide Antagonists,Organothiophosphate Insecticide Antagonists,Antagonists, Organophosphate Insecticide,Antagonists, Organothiophosphate Insecticide,Insecticide Antagonists, Organophosphate,Insecticide Antagonists, Organothiophosphate,Reactivators, Cholinesterase
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000931 Antidotes Agents counteracting or neutralizing the action of POISONS. Antidote,Theriacs
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
July 2017, Molecules (Basel, Switzerland),
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
November 1975, Journal of medicinal chemistry,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
August 1973, Journal of medicinal chemistry,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
December 1977, Il Farmaco; edizione scientifica,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
January 1972, Il Farmaco; edizione scientifica,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
April 1972, Journal of pharmaceutical sciences,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
August 1975, Journal of medicinal chemistry,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
June 2012, Biochemical pharmacology,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
July 2015, Chemico-biological interactions,
C T Su, and P H Wang, and R F Liu, and J H Shih, and C Ma, and C H Lin, and C Y Liu, and M T Wu
November 1984, Journal of medicinal chemistry,
Copied contents to your clipboard!